The key to producing an effective medicinal cannabis product means ensuring quality and compliance is met across the supply chain. We combine our expertise in medicinal cannabis cultivation at Eco Equity and supply & export with our best practise production cycle. Continue reading to learn how genetic development can be .
section-00087c8
section-2d62d7f
section-cabe089
Eco Equity
About UsAt Eco Equity we intend to become world leaders in the production of medicinal cannabis. Supplying extracts and produce such as GMP-Flower, GMP-Oil to the pharmaceutical industry as an API (Active Pharmaceutical Ingredient) to meet the increasing global demand for a high specification medicinal cannabis product and transform lives.
We are based in the heart of London with rapidly expanding production operations in Africa.
JP Doran
section-78ec34f
Our Mission
We are passionate about the scientific evidence that proves the potential of medicinal cannabis and we will provide a highly effective API to the pharmaceutical industry for global distribution.
With agreements already in place to supply GACP & EU-GMP certified medicinal cannabis via our cultivation regions that include R&D facilities and an active breeding programme to create proprietary genetic variants of medicinal cannabis.
section-8a582da
Our Background
We are the first company to hold a medicinal cannabis licence in Zimbabwe.
With our connections and local trust, we feel we have a growing social responsibility to be a part of rebuilding the Zimbabwean economy, you can read more about Our Job Creation and Community Outreach Programs here.
section-11b5ef4
Contact Us
Eco Equity focuses on export to global regions with a heavy destination focus on Europe which is predicted to be the world’s biggest over the next 10 years. According to Prohibition Partners – Europe’s cannabis market is estimated to be worth up to €123 billion by 2028. Eco Equity intends, through first-mover advantage to become the biggest producer of CBD oil in Southern Africa.
To learn more about how to invest, please visit our investment fund-vehicle, JPD Capital.
section-17f7997
FAQ & Information
Get in touch with us here and a member of our team will get back to you within 24 hours.
For comment, interviews and other press & media related enquiries please contact our PR team at BLJ London jonathang@blj.co.uk or visit their website here.
Do you require medicinal cannabis for yourself or a child? You can learn more about how we can support you via the Eco Equity Foundation here
section-c98d27b
Global Distribution Capacity
15,470
Kg
EU-GMP cannabis flower
1,591
Kg
EU-GMP Oil
6
Strains
In Cultivation
section-5c05d9b
Latest News
Our Blog
Lyphe Group Part II: Jonathan Nadler talks post-Brexit supply chain and reducing prescription costs
Brexit has impacted the nation in many ways as we .
We Talk Medicinal Cannabis Access & Mental Health with Jonathan Nadler, MD of Lyphe Group
Jonathan Nadler is the group Managing Director at Lyphe Group, .
© COPYRIGHT ECO EQUITY LIMITED 2021 | ALL RIGHTS RESERVED